1.Understanding of the temporomandibular disorder from the perspectives of the orthodontist.
Korean Journal of Orthodontics 1995;25(5):635-639
No abstract available.
Temporomandibular Joint Disorders*
2.Intra-arterial Cisplatin Chemotherapy in Uterine Cervix Cancer after Selective Internal lilac Arteriography.
Journal of the Korean Radiological Society 1994;30(3):471-479
PURPOSE: Colposcopic response of preoperative uterine cervix carcinomas to intra-arterial cisplatin infusion chemotherapy was analyzed to evaluate the efficacy of this therapy after selective pelvic arteriography. MATERIALS AND METHODS: Nine patients of stage 1/11 cervical carcinomas were treated twice with intra-arterial cisplatin chemotherapy of a 3-week interval, with every week follow-up of colposcopy and histology until the radical hysterectomy and pelvic lymphadenectomy on the 6th week. Cisplatin of 50mg/m~ was slowly infused via autoinjector for 10 minutes with the catheter tip placed in both internal iliac arteries around uterine artery branching. RESULTS: Colposcopic regression rate of tumor size was as follows:more than 2/3 decrease of original size in 2 patients, 2/3-1/2 in 2 patients, less than 1/2 in 4 patients, but in one patient minimal increase in tumor size was recognized. Colposcopic and postoperative microscopic pathology revealed degeneration and necrosis of the tumor cells and/or adjacent lymph nodes and fibrosis of surrounding tissues. All patients have been doing well until postoperative 25 months without recurrence or significant complications. CONCLUSION: Preoperative intra-arterial cisplatin chemotherapy after selective internal iliac rteriography is helpful to decrease tumor size and improve histologic response and prognosis in stage I and II cervical carcinomas.
Angiography*
;
Catheters
;
Cervix Uteri*
;
Cisplatin*
;
Colposcopy
;
Drug Therapy*
;
Female
;
Fibrosis
;
Follow-Up Studies
;
Humans
;
Hysterectomy
;
Iliac Artery
;
Lymph Node Excision
;
Lymph Nodes
;
Necrosis
;
Pathology
;
Prognosis
;
Recurrence
;
Uterine Artery
3.Expression of Epidermal Growth Factor Receptor and Transforming Growth Factor-beta1 Type II Receptor in Oral Leukoplakia and Squamous Cell Carcinoma.
Tae Yeon KIM ; Jong In YOOK ; Jin KIM
Korean Journal of Pathology 1997;31(12):1247-1255
Growth stimulatory/inhibitory factors and their receptors are the important mediators of control of epithelial cell proliferation and differentiation. The aim of this study was to observe the distribution of epidermal growth factor receptor (EGFR) and transforming growth factor-beta1 type II receptor (TbetaRII) during carcinogenesis of oral squamous cell carcinoma (OSCC). Formalin fixed, paraffin embedded tissue from 25 oral leukoplakias (OL) and 15 OSCC was immunostained by avidin-biotin complex method. In OSCC, the carcinomatous area and the adjacent dysplastic/ hyperplastic area were examined. In OL, the hyperplasia and the epithelial dysplasia were examined. Monoclonal anti-EGFR Ab and polyclonal anti-TbetaRII Ab were applied. EGFR was mainly expressed in the basal layer and was increased with epithelial dysplasia in OL. TbetaRII was not detected in the basal cell layer and dysplastic area in OL. In contrast, the dysplastic area adjacent to OSCC showed positivity in the entire layer including the dysplastic area. In all cases of OSCC, both EGFR and TbetaRII showed positive reactions. EGFR was increased with the progression to the malignancy, and the expression pattern of TbetaR II was altered to be positive in the basal cell layer with progression to malignancy. These results suggest that the expression of EGFR appeared to be an early event and TbetaR II may be related to malignant transformation during oral carcinogenesis. The expression pattern of EGFR and TbetaR II may contribute to predict the risk of the development of carcinoma in oral premalignant lesions.
Carcinogenesis
;
Carcinoma, Squamous Cell*
;
Epidermal Growth Factor*
;
Epithelial Cells
;
Formaldehyde
;
Hyperplasia
;
Leukoplakia, Oral*
;
Paraffin
;
Receptor, Epidermal Growth Factor*
5.Factors in Selection of Surgical Approaches for Lower Lumbar Burst Fractures.
Journal of Korean Neurosurgical Society 2000;29(8):1055-1062
No abstract available.
6.The Efficacy of Pelvic Floor Muscles Exercise Combined with Biofeedback and Electrical Stimulation in Recurred Stress In continence or Intrinsic Sphincter Dysfunction Patients.
Korean Journal of Urology 2000;41(1):110-117
No abstract available.
Biofeedback, Psychology*
;
Electric Stimulation*
;
Humans
;
Muscles*
;
Pelvic Floor*
7.The Efficacy of Pelvic Floor Muscles Exercise Combined with Biofeedback and Electrical Stimulation in Recurred Stress In continence or Intrinsic Sphincter Dysfunction Patients.
Korean Journal of Urology 2000;41(1):110-117
No abstract available.
Biofeedback, Psychology*
;
Electric Stimulation*
;
Humans
;
Muscles*
;
Pelvic Floor*
8.In Memoriam: Professor Seung-Yull Cho (1943–2019)
Journal of Korean Medical Science 2019;34(5):e43-
No abstract available.
Parasitology/history
;
Korea
;
Periodicals as Topic
9.LOWER LIP RECONSTRUCTION WITH BARREL-SHAPED EXCISION.
Taik Jong LEE ; Tae Joon KIM ; Jong Pil PARK
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(6):1425-1430
No abstract available.
Lip*
10.A Case of Multiple Bowen' s Disease in a Leprosy Patient.
Tae Jin CHOI ; Chul Jong PARK ; Jong Yuk YI ; Tae Yoon KIM ; Chung Won KIM
Korean Journal of Dermatology 1995;33(6):1134-1137
We report a case of multiple Bowen's disease associated with leprosy. A 68-year-old man was seen because of slightly pruritic multiple erythematous scaly patches and plaques on the trunk and the both extremities for 5 years. He has been treated for leprosy with many kinds of drugs consisting of the herb medications for over 40 years. He also showed decreased cell-mediated immunity in skin tests. It is considered that depressed cellular immunity may be an important predisposing factor in the development of mutiple Bowen's disease in this case, .although arsenics can not be completetly excluded.
Aged
;
Bowen's Disease
;
Causality
;
Extremities
;
Humans
;
Immunity, Cellular
;
Leprosy*
;
Skin Tests